Edward W. Whitehorne, AM, ChairInvestment Consultant, Morrisville, NC
Edward W. Whitehorne brings a diverse blend of financial acumen, investment experience and technical expertise to the position of Chair of the FHI 360 Board of Directors. He has more than three decades of experience as an angel investor and in research and development. In addition, he is a trustee of the FHI Foundation and Chair of its Investment Committee.
Mr. Whitehorne’s career includes positions as chair of two software companies and the chief executive officer of a professional services company that serves the pharmaceutical industry. He has extensive work and consulting experience in the contract research organization industry. He is also a mentor to local entrepreneurs and an investment consultant.
Mr. Whitehorne was a founder of Clinical Research International, a contract research organization (CRO) that was sold and became Clintrials Research, the first publicly traded CRO. The FHI Foundation was created with the proceeds from that sale. Mr. Whitehorne was also a member of the Board of Directors of Novella Clinical, Inc., a leader in oncology and medical device clinical trials. In 2013, he led the sale of Novella to Quintiles, the largest publicly traded CRO.
Mr. Whitehorne has been an active member of the angel investment community since the early 1990s. He was a founding member of TriState Investment Group II, III and IV, as well as The Atlantis Group. He has served in several management positions with all four groups. Mr. Whitehorne has invested in more than 50 early-stage technology and biotechnology companies and has served on the boards of many.
Mr. Whitehorne has a bachelor’s degree in computer science from North Carolina State University, a master’s in computer science from Duke University and completion of coursework and qualifying exams for a doctorate in operations research from North Carolina State University.
Mr. Whitehorne joined the FHI 360 Board of Directors in 2000 and is its Chair.